Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.57 |
| ▸ | ACE | P12821 | 8/20 | 0.57 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.53 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.52 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | CTSS | P25774 | 2/20 | 0.51 |
| ▸ | CTSL | P07711 | 1/20 | 0.51 |
| ▸ | CTSB | P07858 | 1/20 | 0.51 |
| ▸ | CTSK | P43235 | 1/20 | 0.51 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.50 |
| ▸ | CXCR3 | P49682 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27726210 | 1.00 | HDAC8 (0.57) | HDAC8ACEABCB11DPP8DPP9 | |
| SCHEMBL27726211 | 1.00 | HDAC8 (0.57) | HDAC8ACEABCB11DPP8DPP9 | |
| SCHEMBL27726221 | 0.94 | HDAC8 (0.56) | HDAC8ACEABCB11DPP8DPP9 | |
| SCHEMBL27726227 | 0.94 | HDAC8 (0.56) | HDAC8ACEABCB11DPP8DPP9 | |
| SCHEMBL27705637 | 0.92 | HDAC8 (0.58) | HDAC8ACEDPP8DPP9KMT2A | |
| SCHEMBL22962231 | 0.92 | HDAC8 (0.58) | HDAC8ACEDPP8DPP9KMT2A | |
| SCHEMBL27705687 | 0.92 | HDAC8 (0.58) | HDAC8ACEDPP8DPP9KMT2A | |
| SCHEMBL27705696 | 0.90 | ACE (0.55) | HDAC8ACEABCB11CXCR3 | |
| SCHEMBL27705695 | 0.90 | ACE (0.55) | HDAC8ACEABCB11CXCR3 | |
| SCHEMBL28769818 | 0.89 | ACE (0.54) | HDAC8ACEABCB11CXCR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210040150-A1 | KAPPA OPIOID RECEPTOR PEPTIDE AMIDE AGONISTS | YICHANG HUMANWELL PHARMACEUTICALS CO., LTD. (CN) | 2021-02-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210040150-A1 | KAPPA OPIOID RECEPTOR PEPTIDE AMIDE AGONISTS | OPRK1, OPRL1, OPRD1 | HDAC8 3697/4885ACE 1903/4885ABCB11 3299/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.